Copyright Reports & Markets. All rights reserved.

Global Ertapenem for Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ertapenem for Injection Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity >98%
    • 1.3.3 Purity >99%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ertapenem for Injection Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Intravenous Injection
    • 1.4.3 Intramuscular Injection
  • 1.5 Global Ertapenem for Injection Market Size & Forecast
    • 1.5.1 Global Ertapenem for Injection Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Ertapenem for Injection Sales Quantity (2020-2031)
    • 1.5.3 Global Ertapenem for Injection Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Savior Lifetec Corporation
    • 2.1.1 Savior Lifetec Corporation Details
    • 2.1.2 Savior Lifetec Corporation Major Business
    • 2.1.3 Savior Lifetec Corporation Ertapenem for Injection Product and Services
    • 2.1.4 Savior Lifetec Corporation Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Savior Lifetec Corporation Recent Developments/Updates
  • 2.2 ACS Dobfar
    • 2.2.1 ACS Dobfar Details
    • 2.2.2 ACS Dobfar Major Business
    • 2.2.3 ACS Dobfar Ertapenem for Injection Product and Services
    • 2.2.4 ACS Dobfar Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 ACS Dobfar Recent Developments/Updates
  • 2.3 Zhejiang Hisun Pharmaceutical
    • 2.3.1 Zhejiang Hisun Pharmaceutical Details
    • 2.3.2 Zhejiang Hisun Pharmaceutical Major Business
    • 2.3.3 Zhejiang Hisun Pharmaceutical Ertapenem for Injection Product and Services
    • 2.3.4 Zhejiang Hisun Pharmaceutical Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
  • 2.4 Sun Pharma
    • 2.4.1 Sun Pharma Details
    • 2.4.2 Sun Pharma Major Business
    • 2.4.3 Sun Pharma Ertapenem for Injection Product and Services
    • 2.4.4 Sun Pharma Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sun Pharma Recent Developments/Updates
  • 2.5 Zhejiang Hisoar
    • 2.5.1 Zhejiang Hisoar Details
    • 2.5.2 Zhejiang Hisoar Major Business
    • 2.5.3 Zhejiang Hisoar Ertapenem for Injection Product and Services
    • 2.5.4 Zhejiang Hisoar Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhejiang Hisoar Recent Developments/Updates
  • 2.6 Kaliberr Labs
    • 2.6.1 Kaliberr Labs Details
    • 2.6.2 Kaliberr Labs Major Business
    • 2.6.3 Kaliberr Labs Ertapenem for Injection Product and Services
    • 2.6.4 Kaliberr Labs Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Kaliberr Labs Recent Developments/Updates
  • 2.7 Qilu Pharmaceutical
    • 2.7.1 Qilu Pharmaceutical Details
    • 2.7.2 Qilu Pharmaceutical Major Business
    • 2.7.3 Qilu Pharmaceutical Ertapenem for Injection Product and Services
    • 2.7.4 Qilu Pharmaceutical Ertapenem for Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Qilu Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Ertapenem for Injection by Manufacturer

  • 3.1 Global Ertapenem for Injection Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Ertapenem for Injection Revenue by Manufacturer (2020-2025)
  • 3.3 Global Ertapenem for Injection Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Ertapenem for Injection by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Ertapenem for Injection Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Ertapenem for Injection Manufacturer Market Share in 2024
  • 3.5 Ertapenem for Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Ertapenem for Injection Market: Region Footprint
    • 3.5.2 Ertapenem for Injection Market: Company Product Type Footprint
    • 3.5.3 Ertapenem for Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ertapenem for Injection Market Size by Region
    • 4.1.1 Global Ertapenem for Injection Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Ertapenem for Injection Consumption Value by Region (2020-2031)
    • 4.1.3 Global Ertapenem for Injection Average Price by Region (2020-2031)
  • 4.2 North America Ertapenem for Injection Consumption Value (2020-2031)
  • 4.3 Europe Ertapenem for Injection Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Ertapenem for Injection Consumption Value (2020-2031)
  • 4.5 South America Ertapenem for Injection Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Ertapenem for Injection Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Ertapenem for Injection Sales Quantity by Type (2020-2031)
  • 5.2 Global Ertapenem for Injection Consumption Value by Type (2020-2031)
  • 5.3 Global Ertapenem for Injection Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Ertapenem for Injection Sales Quantity by Application (2020-2031)
  • 6.2 Global Ertapenem for Injection Consumption Value by Application (2020-2031)
  • 6.3 Global Ertapenem for Injection Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Ertapenem for Injection Sales Quantity by Type (2020-2031)
  • 7.2 North America Ertapenem for Injection Sales Quantity by Application (2020-2031)
  • 7.3 North America Ertapenem for Injection Market Size by Country
    • 7.3.1 North America Ertapenem for Injection Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Ertapenem for Injection Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Ertapenem for Injection Sales Quantity by Type (2020-2031)
  • 8.2 Europe Ertapenem for Injection Sales Quantity by Application (2020-2031)
  • 8.3 Europe Ertapenem for Injection Market Size by Country
    • 8.3.1 Europe Ertapenem for Injection Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Ertapenem for Injection Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ertapenem for Injection Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Ertapenem for Injection Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Ertapenem for Injection Market Size by Region
    • 9.3.1 Asia-Pacific Ertapenem for Injection Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Ertapenem for Injection Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Ertapenem for Injection Sales Quantity by Type (2020-2031)
  • 10.2 South America Ertapenem for Injection Sales Quantity by Application (2020-2031)
  • 10.3 South America Ertapenem for Injection Market Size by Country
    • 10.3.1 South America Ertapenem for Injection Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Ertapenem for Injection Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ertapenem for Injection Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Ertapenem for Injection Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Ertapenem for Injection Market Size by Country
    • 11.3.1 Middle East & Africa Ertapenem for Injection Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Ertapenem for Injection Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Ertapenem for Injection Market Drivers
  • 12.2 Ertapenem for Injection Market Restraints
  • 12.3 Ertapenem for Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ertapenem for Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ertapenem for Injection
  • 13.3 Ertapenem for Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ertapenem for Injection Typical Distributors
  • 14.3 Ertapenem for Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ertapenem for Injection market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
    In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Ertapenem for Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ertapenem for Injection market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Ertapenem for Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Ertapenem for Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
    Global Ertapenem for Injection market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ertapenem for Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ertapenem for Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Savior Lifetec Corporation, ACS Dobfar, Zhejiang Hisun Pharmaceutical, Sun Pharma, Zhejiang Hisoar, Kaliberr Labs, Qilu Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ertapenem for Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Purity >98%
    Purity >99%
    Market segment by Application
    Intravenous Injection
    Intramuscular Injection
    Major players covered
    Savior Lifetec Corporation
    ACS Dobfar
    Zhejiang Hisun Pharmaceutical
    Sun Pharma
    Zhejiang Hisoar
    Kaliberr Labs
    Qilu Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ertapenem for Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ertapenem for Injection, with price, sales quantity, revenue, and global market share of Ertapenem for Injection from 2020 to 2025.
    Chapter 3, the Ertapenem for Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ertapenem for Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Ertapenem for Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ertapenem for Injection.
    Chapter 14 and 15, to describe Ertapenem for Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now